IMMU-22. ALLOGENEIC NK CELLS SECRETING IL15 AND RESISTANT TO TGF-β Show Antitumor Activity Against Gliobastoma
نویسندگان
چکیده
Abstract INTRODUCTION High grade brain cancers, like most solid tumors, often relapse and are resistant to current therapies. Limited efficacy cell therapy may be related intratumoral heterogeneity the suppressive tumor microenvironment. Hence, we aimed modify allogeneic natural killer (NK) cells, which can recognize expressed stress ligands, resist TGF-β secrete IL15. METHODS Cord blood-derived NK cells were expanded modified express IL15 a dominant negative receptor (DNR) against TGF-β. product activity GBM line U87MG evaluated in vitro vivo. The behavior of these also analyzed ex vivo, evaluate impact (including potential toxicity) increasing potency this product. RESULTS While animals injected with secreting expressing DNR successfully cleared tumors 6 days after T infusion, did not observe significant differences survival between groups (no treatment control mice vs treated mock-transduced DNR-transduced IL-15/DNR-transduced cells). Therefore, sought determine whether cytokine-related toxicity was responsible for death setting clearance. We compared no or products. Elevated levels IL-15 detected plasma cells. These elevated corresponded persistence measured by ddPCR. However, other cytokines upregulated. CONCLUSIONS observed improved clearance when both protected immune capable stimulatory cytokine currently performing additional experiments from secretion occurs. To potentially mitigate plan engineer suicide gene into constructs.
منابع مشابه
Arming NK cells with enhanced antitumor activity
Natural killer (NK) cells hold great promise for adoptive cancer immunotherapy. The antitumor activity of NK cells can be enhanced by the transgene driven expression of chimeric antigen receptors that facilitate the selective recognition and killing of malignant cells. Recent data from our laboratory suggest that NK cells may similarly be "armed" against neoplastic cells by the expression of ca...
متن کاملIL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection
BACKGROUND Natural killer (NK) cells play cytotoxic roles by targeting tumor cells or virus infected cells, they also play regulatory roles by secreting cytokines and chemokines. Transforming growth factor (TGF)-β and interleukin (IL)-10 are important immunosuppressive cytokines potentially related to the immune dysregulation that occurs in the infection of human immunodeficiency virus (HIV). N...
متن کاملAutoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
A CD4+ heat shock protein (hsp) 60-recognizing autoreactive T-cell line (BASL1) and clone (BASL1.1) were examined for their antitumor activity against major histocompatibility complex class II- syngeneic Meth A fibrosarcoma (Meth A), which was immunofluorescently stained with monoclonal antibody specific for hsp 60. In in vitro proliferative assay, BASL1.1 was suggested to recognize Meth A-deri...
متن کاملAntimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells
BACKGROUND This study evaluated the cytotoxic and antiproliferative efficacy of two well-characterized members of the Cecropin-family of antimicrobial peptides against bladder tumor cells and benign fibroblasts. METHODS The antiproliferative and cytotoxic potential of the Cecropins A and B was quantified by colorimetric WST-1-, BrdU- and LDH-assays in four bladder cancer cell lines as well as...
متن کاملMyxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
Myxoma virus, a rabbit poxvirus, can efficiently infect various types of mouse and human cancer cells. It is a strict rabbit-specific pathogen, and is thought to be safe as a therapeutic agent in all non-rabbit hosts tested including mice and humans. Interleukin-15 (IL15) is an immuno-modulatory cytokine with significant potential for stimulating anti-tumor T lymphocytes and NK cells. Co-expres...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2023
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noad073.209